Trial
NCT03000660
Trial of Venetoclax (ABT-199) and Dexamethasone for Relapsed or Refractory Systemic AL Amyloidosis
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Tufts Medical Center
Collaborators
—
Condition
AL Amyloidosis
Intervention
Venetoclax
Why stopped
partial clinical hold per FDA
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-08-21